ICER 2023: Circular targets remain out of reach The Netherlands aims to have a fully circular economy by 2050 and halve its use of raw materials by 2030. In recent years, however, little progress has been made in either regard.
Vaccination coverage for autumn round: Downward trend in Health & Welfare sector continues – 69% of nationwide medical high-risk groups were vaccinated At the start of the autumn round, from mid-September 2022, the first group to be offered a repeat vaccination against COVID-19 was people with an elevated risk of a severe course of illness and care workers who have contact with patients and/or clients
Circular economy: plastics recycling from end-of-life vehicles could be four times higher At present, 85% of plastics from end-of-life vehicles is still incinerated. Only 15% of plastics is reused as a raw material. A survey conducted by RIVM has revealed possibilities to expand recovery of these plastics fourfold by 2030.
Repeat vaccination against COVID-19 now also available for over-60s People aged 60 to 69 years (and people who turn 60 this year) will also have the opportunity to make an appointment for an extra COVID-19 vaccination. Minister Kuipers decided this based on advice from the Health Council of the Netherlands.
Janssen booster possible as of 25 March People in the Netherlands who cannot get a booster with an mRNA vaccine for medical reasons, or do not want an mRNA vaccine as a booster, can make an appointment for a booster vaccination with Janssen from Wednesday 23 March on.
Protection from COVID-19 booster wanes slightly after 3 months among over-70s In the period from 1 February to 8 March 2022, the first indications were observed that protection against hospital admission after COVID-19 booster vaccination decreases over time in people over 7
Novavax vaccine available The Novavax vaccine is a protein-based vaccine which can offer an alternative for people who are hesitant about immunisation with an mRNA vaccine or vector vaccine, or for people who have a contraindication for mRNA vaccines.